Emma Yasinski is a freelance writer covering biology, neuroscience and medicine. Her stories have appeared in The Scientist, Discover Magazine, Smithsonian Magazine, Kaiser Health News and other publications. Yasinski has an M.Sc. in science and medical journalism from Boston University and a B.S. in neuroscience from Lafayette College in Easton, Pennsylvania.
Emma Yasinski
Contributing writer
From this contributor
Parental care may sculpt brain development in prairie voles
Voles reared primarily by their fathers show altered synapse density.
Parental care may sculpt brain development in prairie voles
By
Emma Yasinski
1 September 2023 | 3 min read
Social-pragmatic difficulties common with autism, other diagnoses
A standard questionnaire can help identify social (pragmatic) communication disorder more readily in school-age children.
Social-pragmatic difficulties common with autism, other diagnoses
By
Emma Yasinski
4 October 2022 | 4 min read
Fragile X neurons develop atypically in chimeric mice
After a brain transplant of reprogrammed human cells, the animals can for the first time recapitulate some neuronal changes seen in people with fragile X syndrome.
Fragile X neurons develop atypically in chimeric mice
By
Emma Yasinski
29 September 2022 | 4 min read
Inflexible thinking in adolescence linked to emotional, behavioral issues in adulthood
Treating cognitive inflexibility — for example, by practicing problem-solving — might help ease anxiety and depression in autistic people.
Inflexible thinking in adolescence linked to emotional, behavioral issues in adulthood
By
Emma Yasinski
22 October 2021 | 3 min read
Mutations linked to autism may be detectable in men’s sperm
An advanced DNA-sequencing technique has identified gene-damaging mutations, some with ties to autism, in about 1 in 15 men.
Mutations linked to autism may be detectable in men’s sperm
By
Emma Yasinski
16 September 2021 | 5 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read